No retraction, correction or concern found when last checked on Nov 2, 2026.
Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases
Un Yung Choi, Ji-Seon Kang, Yune Sahng Hwang and 1 more
Experimental & Molecular Medicine · 2015 · Review · CC BY
Abstract
The study of antiviral pathways to reveal methods for the effective response and clearance of virus is closely related to understanding interferon (IFN) signaling and its downstream target genes, IFN-stimulated genes. One of the key antiviral factors induced by IFNs, 2′-5′ oligoadenylate synthase (OAS), is a well-known molecule that regulates the early phase of viral infection by degrading viral RNA in combination with RNase L, resulting in the inhibition of viral replication. In this review, we describe OAS family proteins from a different point of view from that of previous reviews. We discuss not only RNase L-dependent (canonical) and -independent (noncanonical) pathways but also the possibility of the OAS family members as biomarkers for various diseases and clues to non-immunological functions based on recent studies. In particular, we focus on OASL, a member of the OAS family that is relatively less well understood than the other members. We will explain its anti- and pro-viral dual roles as well as the diseases related to single-nucleotide polymorphisms in the corresponding gene.
Cited by papers we hold 5
- A genomic region associated with protection against severe COVID-19 is inherited from Neandertals · 2021No notice
- Identification of candidate biomarkers and pathways associated with psoriasis using bioinformatics analysis · 2020Not checked
- An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells · 2020No notice
- Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication · 2017No notice
- Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways · 2015No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.